サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1193271

脊椎内視鏡手術市場：製品タイプ別、施術タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Endoscopic Spinal Surgery Market By Product Type, By Procedure type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 236 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脊椎内視鏡手術市場：製品タイプ別、施術タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 236 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脊椎内視鏡手術の世界市場は、2021年に5億3690万米ドルと評価され、2031年には10億9631万米ドルに達し、2022年から2031年までのCAGRは7.4%を記録すると予測されています。

脊椎内視鏡手術（ESS）は、1インチ以下の極小切開と、内視鏡とともに小さな管状のシステムを利用して、人体の内部器官を鮮明に映し出す手術方法とされています。ESSが提供する光学技術の進歩、組織の高品質な可視化、効率的な脊髄画像により、このタイプの脊髄手術は現在多くの患者の治療の選択肢となっています。また、この手術は低侵襲手術の一つであり、術後の回復が早いのが特徴です。さらに、この手術では、管状のレトラクターと内視鏡を使用するため、内臓を間接的に可視化することができます。さらに、手術中の間接的な可視化は、多くの異なる外科専門分野にわたって、従来の直接可視化に取って代わり、脊椎内視鏡手術の需要をさらに高めています。

世界保健機関（WHO）によると、2030年には世界で約10億人の高齢者がいると予想されており、これは全人口の12%に相当します。老年人口の割合は、その後の20年間、増加し続けると予想されています。2050年には、世界の高齢者人口は16億人になり、世界総人口94億人の16.7%に相当すると推定されています。さらに、いくつかの研究によると、高齢者は腰痛や脊椎関節炎など、加齢に伴う慢性疾患にかかりやすく、特別な治療が必要になる可能性があることが報告されています。

このように高齢者人口の増加が予想されることから、痛みが少なく回復が早い脊椎内視鏡手術の需要が高まり、予測期間中の市場拡大がさらに進むと考えられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 脊椎内視鏡手術市場：製品タイプ別

  • 概要
    • 市場規模および予測
  • 内視鏡
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 内視鏡デバイス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第5章 脊椎内視鏡手術市場：施術タイプ別

  • 概要
    • 市場規模および予測
  • 経腔鏡下内視鏡下手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 層間内視鏡手術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 後方椎間孔拡大術および頸部椎間板切除術
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 内視鏡リゾトミー
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第6章 脊椎内視鏡手術市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 病院とクリニック
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 外来手術センター
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第7章 脊椎内視鏡手術市場：地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模・予測：製品タイプ別
    • 北米市場規模・予測：施術タイプ別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測：製品タイプ別
    • 欧州市場規模・予測：施術タイプ別
    • 欧州市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他の欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：製品タイプ別
    • アジア太平洋地域の市場規模・予測：施術タイプ別
    • アジア太平洋地域の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：国別
      • 日本
      • 中国
      • オーストラリア
      • インド
      • 韓国
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：製品タイプ別
    • LAMEAの市場規模・予測：施術タイプ別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ共和国
      • LAMEAの残りの地域

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • DEPUY SYNTHES SPINE, INC.（JOHNSON & JOHNSON）
  • MEDTRONIC PLC.
  • MEDICALTEK CO., LTD.
  • STRYKER CORPORATION
  • ZIMMER BIOMET HOLDINGS, INC.
  • OLYMPUS CORPORATION
  • KARL STORZ SE & CO. KG
  • Richard Wolf GmbH
  • GLOBUS MEDICAL INC.
  • Endovision Co., Ltd.
  • joimax GmbH
図表

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC DEVICES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. ENDOSCOPIC SPINAL SURGERY MARKET FOR TRANSFORAMINAL ENDOSCOPIC PROCEDURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. ENDOSCOPIC SPINAL SURGERY MARKET FOR TRANSFORAMINAL ENDOSCOPIC PROCEDURES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. ENDOSCOPIC SPINAL SURGERY MARKET FOR INTERLAMINAR ENDOSCOPIC PROCEDURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. ENDOSCOPIC SPINAL SURGERY MARKET FOR INTERLAMINAR ENDOSCOPIC PROCEDURES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC VISUALIZED RHIZOTOMY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC VISUALIZED RHIZOTOMY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. ENDOSCOPIC SPINAL SURGERY MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. ENDOSCOPIC SPINAL SURGERY MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. ENDOSCOPIC SPINAL SURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. ENDOSCOPIC SPINAL SURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): COMPANY SNAPSHOT
  • TABLE 95.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): OPERATING SEGMENTS
  • TABLE 96.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): PRODUCT PORTFOLIO
  • TABLE 97.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): NET SALES
  • TABLE 98.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): KEY STRATERGIES
  • TABLE 99.MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 100.MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 101.MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 102.MEDTRONIC PLC.: NET SALES
  • TABLE 103.MEDTRONIC PLC.: KEY STRATERGIES
  • TABLE 104.MEDICALTEK CO., LTD.: COMPANY SNAPSHOT
  • TABLE 105.MEDICALTEK CO., LTD.: OPERATING SEGMENTS
  • TABLE 106.MEDICALTEK CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 107.MEDICALTEK CO., LTD.: NET SALES
  • TABLE 108.MEDICALTEK CO., LTD.: KEY STRATERGIES
  • TABLE 109.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 110.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 111.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 112.STRYKER CORPORATION: NET SALES
  • TABLE 113.STRYKER CORPORATION: KEY STRATERGIES
  • TABLE 114.ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
  • TABLE 115.ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
  • TABLE 116.ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
  • TABLE 117.ZIMMER BIOMET HOLDINGS, INC.: NET SALES
  • TABLE 118.ZIMMER BIOMET HOLDINGS, INC.: KEY STRATERGIES
  • TABLE 119.OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 120.OLYMPUS CORPORATION: OPERATING SEGMENTS
  • TABLE 121.OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 122.OLYMPUS CORPORATION: NET SALES
  • TABLE 123.OLYMPUS CORPORATION: KEY STRATERGIES
  • TABLE 124.KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
  • TABLE 125.KARL STORZ SE & CO. KG: OPERATING SEGMENTS
  • TABLE 126.KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
  • TABLE 127.KARL STORZ SE & CO. KG: NET SALES
  • TABLE 128.KARL STORZ SE & CO. KG: KEY STRATERGIES
  • TABLE 129.RICHARD WOLF GMBH: COMPANY SNAPSHOT
  • TABLE 130.RICHARD WOLF GMBH: OPERATING SEGMENTS
  • TABLE 131.RICHARD WOLF GMBH: PRODUCT PORTFOLIO
  • TABLE 132.RICHARD WOLF GMBH: NET SALES
  • TABLE 133.RICHARD WOLF GMBH: KEY STRATERGIES
  • TABLE 134.GLOBUS MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 135.GLOBUS MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 136.GLOBUS MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 137.GLOBUS MEDICAL INC.: NET SALES
  • TABLE 138.GLOBUS MEDICAL INC.: KEY STRATERGIES
  • TABLE 139.ENDOVISION CO., LTD.: COMPANY SNAPSHOT
  • TABLE 140.ENDOVISION CO., LTD.: OPERATING SEGMENTS
  • TABLE 141.ENDOVISION CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 142.ENDOVISION CO., LTD.: NET SALES
  • TABLE 143.ENDOVISION CO., LTD.: KEY STRATERGIES
  • TABLE 144.JOIMAX GMBH: COMPANY SNAPSHOT
  • TABLE 145.JOIMAX GMBH: OPERATING SEGMENTS
  • TABLE 146.JOIMAX GMBH: PRODUCT PORTFOLIO
  • TABLE 147.JOIMAX GMBH: NET SALES
  • TABLE 148.JOIMAX GMBH: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ENDOSCOPIC SPINAL SURGERY MARKET SEGMENTATION
  • FIGURE 2.ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031
  • FIGURE 3.ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ENDOSCOPIC SPINAL SURGERY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.ENDOSCOPIC SPINAL SURGERY MARKET,BY PRODUCT TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPES ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPIC DEVICES ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 15.ENDOSCOPIC SPINAL SURGERY MARKET,BY PROCEDURE TYPE,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF TRANSFORAMINAL ENDOSCOPIC PROCEDURES ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF INTERLAMINAR ENDOSCOPIC PROCEDURES ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPIC VISUALIZED RHIZOTOMY ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 20.ENDOSCOPIC SPINAL SURGERY MARKET,BY END USER,2021(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITAL AND CLINICS ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 23.ENDOSCOPIC SPINAL SURGERY MARKET BY REGION,2021
  • FIGURE 24.U.S. ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 25.CANADA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 26.MEXICO ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 27.GERMANY ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 28.FRANCE ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 29.UK ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 30.ITALY ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 31.SPAIN ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 32.REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 33.JAPAN ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 34.CHINA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 35.AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 36.INDIA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 37.SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 38.REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 39.BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 40.SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 41.SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 42.REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47.COMPETITIVE DASHBOARD
  • FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 49.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON).: NET SALES ($MILLION)
  • FIGURE 50.MEDTRONIC PLC..: NET SALES ($MILLION)
  • FIGURE 51.MEDICALTEK CO., LTD..: NET SALES ($MILLION)
  • FIGURE 52.STRYKER CORPORATION.: NET SALES ($MILLION)
  • FIGURE 53.ZIMMER BIOMET HOLDINGS, INC..: NET SALES ($MILLION)
  • FIGURE 54.OLYMPUS CORPORATION.: NET SALES ($MILLION)
  • FIGURE 55.KARL STORZ SE & CO. KG.: NET SALES ($MILLION)
  • FIGURE 56.RICHARD WOLF GMBH.: NET SALES ($MILLION)
  • FIGURE 57.GLOBUS MEDICAL INC..: NET SALES ($MILLION)
  • FIGURE 58.ENDOVISION CO., LTD..: NET SALES ($MILLION)
  • FIGURE 59.JOIMAX GMBH.: NET SALES ($MILLION)
目次
Product Code: A31581

The global endoscopic spinal surgery market was valued at $536.9 million in 2021, and is projected to reach $1,096.31 million by 2031, registering a CAGR of 7.4% from 2022 to 2031.

Endoscopic spinal surgery (ESS) is referred to surgical procedure, which utilizes a micro-sized incisions which is less than 1-inch and a small tubular system together with an endoscope to get clear image of the internal organs of the human body. This type of spinal surgeries has now become a choice of treatment for many patients owing to the advances in optics, high quality visualization of tissues, and efficient spinal imaging that is offered by ESS. In addition, this procedure is one of the minimally invasive surgeries that provide patients fastest recovery after the surgery. Furthermore, the surgery involves use of tubular retractors and endoscope, which allows indirect visualization of the internal organs. In addition, indirect visualization during procedures has been replaced the traditional forms of direct visualization across many different surgical specialties, which further increases demand for endoscopic spinal surgery.

According to the World Health Organization (WHO), in 2030, it is anticipated there will be about 1 billion older people worldwide, which is equivalent to 12% of the total population. The share of geriatric population is anticipated to continue to grow in the following 20 years. By 2050, it is estimated that there will be 1.6 billion older people worldwide, representing 16.7% of the total world population of 9.4 billion. In addition, according to several studies, it is reported that geriatric population is more prone to several age-related chronic illnesses such as lower back pain and spinal arthritis that may require special treatment procedures.

This anticipated rise in the number of aged population propel demand for endoscopic spinal surgeries as the treatment option as it is less painful and offers faster recovery, which further leads to expansion of the market during the forecast period.

In addition, there is a rise in cases of the spinal disorders such as ankylosing spondylitis, spinal stenosis, herniated discs, hematoma, degenerative disc disease, vertebral fractures and others. According to the Johns Hopkins Arthritis Center, in the recent population estimates indicate that the prevalence of ankylosing spondylitis (AS) in the U.S. is approximately 0.2-0.5% and based on data from multiple countries, the age- and sex-adjusted incidence of ankylosing spondylitis (AS) is 0.4-14 per 100,000 people. In addition, in a year about 2% of people get a herniated disk. Thus, there is a huge prevalence of spinal disorders around the globe, which also increases demand for endoscopic spinal surgery, thereby boosting adoption of instruments associated with the surgery. This further propels growth of the endoscopic spinal surgery market.

Furthermore, technological advancements in this field have led to increase in adoption of this technique among the healthcare providers and also by the patients. Complexity of spinal surgery causes serious obstacles during the procedure, and can lead to less effective surgery, therefore, to overcome this, huge technological advances have been made by researchers. Moreover, use of 3D endoscopes have reduced the risk of damage and enhanced accuracy of the procedure. For instance, introduction of a highly precise procedure for endoscopic spinal surgery with the combination of four key technologies including 3D analysis, advanced algorithms, patient connection platform, and cross modality image registration developed by Mazor Robotics. In addition, governments and other organizations provide fundings to initiate research and development activities in certain regions to bring development in healthcare facilities. This also accelerates growth of the market.

In addition, factors such as rise in adoption of minimally invasive spinal surgeries, increase in prevalence of spinal disorders, and increase in geriatric population around the globe propel growth of the market. Although there are many factors driving growth of the market, high cost associated with endoscopic spine surgery and lack of adequate reimbursement policies in emerging regions hampers growth of the market.

The endoscopic spinal surgery market is studied on the basis of product type, procedure type, end user, and region. By product type, the market is segmented into endoscopes and endoscopic devices. By procedure type, transforaminal endoscopic procedures, interlaminar endoscopic procedures, endoscopic posterior foraminotomy & cervical discectomy and endoscopic visualized rhizotomy. By end user, it is classified into hospitals & clinics and ambulatory surgical centers. Region wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Endovision Co. Ltd, Globus Medical Inc., Jiomax Inc., Johnson & Johnson (Depuy Synthes Spine, Inc.),  Karl Storz Se & Co. Kg, Medtronic Plc., Medicaltek Co., Ltd., Olympus Corporation, Richard Wolf, Stryker Corporation, and Zimmer Biomet Holdings, Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the endoscopic spinal surgery market analysis from 2021 to 2031 to identify the prevailing endoscopic spinal surgery market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the endoscopic spinal surgery market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global endoscopic spinal surgery market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Endoscopes
  • Endoscopic Devices

By Procedure type

  • Transforaminal Endoscopic Procedures
  • Interlaminar Endoscopic Procedures
  • Endoscopic Posterior Foraminotomy and Cervical Discectomy
  • Endoscopic Visualized Rhizotomy

By End User

  • Hospital and Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
    • MEDTRONIC PLC.
    • MEDICALTEK CO., LTD.
    • STRYKER CORPORATION
    • ZIMMER BIOMET HOLDINGS, INC.
    • OLYMPUS CORPORATION
    • KARL STORZ SE & CO. KG
    • Richard Wolf GmbH
    • GLOBUS MEDICAL INC.
    • Endovision Co., Ltd.
    • joimax GmbH

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Endoscopes
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Endoscopic Devices
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Transforaminal Endoscopic Procedures
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Interlaminar Endoscopic Procedures
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4 Endoscopic Posterior Foraminotomy and Cervical Discectomy
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country
  • 5.5 Endoscopic Visualized Rhizotomy
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market share analysis by country

CHAPTER 6: ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospital and Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country

CHAPTER 7: ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product Type
    • 7.2.3 North America Market size and forecast, by Procedure type
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product Type
      • 7.2.5.1.3 Market size and forecast, by Procedure type
      • 7.2.5.1.4 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product Type
      • 7.2.5.2.3 Market size and forecast, by Procedure type
      • 7.2.5.2.4 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product Type
      • 7.2.5.3.3 Market size and forecast, by Procedure type
      • 7.2.5.3.4 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product Type
    • 7.3.3 Europe Market size and forecast, by Procedure type
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product Type
      • 7.3.5.1.3 Market size and forecast, by Procedure type
      • 7.3.5.1.4 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product Type
      • 7.3.5.2.3 Market size and forecast, by Procedure type
      • 7.3.5.2.4 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product Type
      • 7.3.5.3.3 Market size and forecast, by Procedure type
      • 7.3.5.3.4 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product Type
      • 7.3.5.4.3 Market size and forecast, by Procedure type
      • 7.3.5.4.4 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product Type
      • 7.3.5.5.3 Market size and forecast, by Procedure type
      • 7.3.5.5.4 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product Type
      • 7.3.5.6.3 Market size and forecast, by Procedure type
      • 7.3.5.6.4 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Procedure type
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product Type
      • 7.4.5.1.3 Market size and forecast, by Procedure type
      • 7.4.5.1.4 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product Type
      • 7.4.5.2.3 Market size and forecast, by Procedure type
      • 7.4.5.2.4 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product Type
      • 7.4.5.3.3 Market size and forecast, by Procedure type
      • 7.4.5.3.4 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product Type
      • 7.4.5.4.3 Market size and forecast, by Procedure type
      • 7.4.5.4.4 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product Type
      • 7.4.5.5.3 Market size and forecast, by Procedure type
      • 7.4.5.5.4 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product Type
      • 7.4.5.6.3 Market size and forecast, by Procedure type
      • 7.4.5.6.4 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product Type
    • 7.5.3 LAMEA Market size and forecast, by Procedure type
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product Type
      • 7.5.5.1.3 Market size and forecast, by Procedure type
      • 7.5.5.1.4 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product Type
      • 7.5.5.2.3 Market size and forecast, by Procedure type
      • 7.5.5.2.4 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product Type
      • 7.5.5.3.3 Market size and forecast, by Procedure type
      • 7.5.5.3.4 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product Type
      • 7.5.5.4.3 Market size and forecast, by Procedure type
      • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 MEDTRONIC PLC.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 MEDICALTEK CO., LTD.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 STRYKER CORPORATION
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 ZIMMER BIOMET HOLDINGS, INC.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 OLYMPUS CORPORATION
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 KARL STORZ SE & CO. KG
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Richard Wolf GmbH
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 GLOBUS MEDICAL INC.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Endovision Co., Ltd.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 joimax GmbH
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments